الفهرس 
Neonatal hyperbilirubinemiaOnly 14 pages are availabe for public view
 |  | from | 126 |  |  |
| | | from | 126 | | |
Abstract
Hyperbilirubinemia is a common condition among preterm
infants in the neonatal intensive care unit (NICU). Jaundice is
observed during first week of life in approximately 60% of term
neonates and 80 % of preterm neonates.
Jaundice is easily diagnosable however require quick and on
the spot treatment. If not treated properly, it leads to many
complications. It occurs as a result of exaggerated neonatal red cell,
hepatic, and gastrointestinal immaturity. Preterm infants are
metabolically immature and at higher risk for bilirubin-induced
neurologic dysfunction at lower bilirubin levels than their term
counterparts.
Total serum bilirubin (TSB) estimation is the gold standard for
diagnosing hyperbilirubinemia however, it is an invasive method that
requires drawing blood, and is also inconvenient because of technical
difficulties in venous puncture, discomfort, pain, delay in results and
parental stress; so, it is important to reducethe number of draws and
minimize the amount of blood the newborn loses due to blood draws.
Transcutaneous bilirubinometry (TcB) was originally developed
as a potential replacement for invasive blood sampling. The use of a
TcB meter in preterm infants can be a reliable noninvasive screening
tool for hyperbilirubinemia, and it may be beneficial in decreasing
painful stimuli and iatrogenic blood loss when used as an adjunct to
TSB monitoring. So, this study aimed to determine and compare the
diagnostic accuracy of transcutaneous bilirubin (TcB) measured at
different body sites in neonates.
To elucidate our aim ; this study was a prospective
observational study was conducted on 131 participants (Neonates) at
the Neonatal Intensive Care Unit (NICU) of Menoufia University
Hospital and Al Helal Insurance Hospita, during the period study from
March 2022 till January 2023.